1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 01 FEBRUARY 2016

World Generic Markets 01 FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - ANDA Approvals Set To See Significant Increase In 2016
Industry Brief - Aurobindo Gains FDA Tranexamic Acid Approval
Industry Brief - FDA Accepts Amgen's Biosimilar Adalimumab For Review
Industry Brief - Perrigo Completes Generic Tretinoin Portfolio Acquisition
Industry Brief - Amneal, Aurobindo Gain FDA Paricalcitol Approvals
Industry Brief - Granules Enters OTC Omeprazole Agreement With Par
Industry Brief - Aurobindo Gains FDA Voriconazole Approval
Industry Brief - Dr Reddy's Gains FDA Sumatriptan Approval
Industry Brief - Dr Reddy's Receives Doxycycline Tentative Approval
Industry Brief - Sun Launches Imatinib Mesylate In US
Industry Trend Analysis - Muted Pressure On Generic Pricing To Be Expected
Industry Brief - ANI Acquires Three Generics From H2-Pharma
Industry Brief - Impax Gains Tentative Ezetimibe+Simvastatin Approval
Industry Brief - Teligent Gains Lidocaine Approval
Industry Trend Analysis - Gilead In Strong Position To Counter TAF Lawsuit
Industry Brief - Eagle Launches Alcohol-Free Docetaxel
Industry Trend Analysis - Resumption Of Trade Talks Will Be Litmus Test For EU
Industry Trend Analysis - Market Conditions Challenge Sandoz But Biosimilars Provide Optimism
Industry Brief - Biocad's Trastuzumab Approved In Russia
Industry Brief - Lek Opens New Laboratory In Menges
Industry Trend Analysis - Sub-Licences Put MPP On The Cusp Of New Era
Industry Brief - Richter Acquires Joint Venture Partner In China
Industry Trend Analysis - Compulsory Licence Rejection Will Secure Onglyza Emerging Market Sales
Industry Brief - Kyowa Hakko Kirin Enters Rituximab Agreement With Sandoz
Company Brief - Positive Phase III Results Reported For CHS-0214

Table Of Contents

World Generic Markets 01 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.